Literature DB >> 4157337

Ampicillin resistance of Shigella sonnei.

J T Smith, D A Bremner, N Datta.   

Abstract

The ampicillin resistance of clinical isolates of Shigella sonnei is due to beta-lactamase production. Two kinds of resistance are found: low level, nontransmissible; and high level, tranmissible. The nontransmissible type of resistance results from a chromosomal mutation which increases the production of a beta-lactamase that hydrolyses cephalosporins relatively rapidly and gives cephalothin resistance. The transmissible type of resistance is due to an R factor mediating the synthesis of a different beta-lactamase that does not significantly hydrolyze cephalosporins or confer cephalothin resistance. One clinical isolate is shown to possess simultaneously both these mechanisms of ampicillin resistance.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4157337      PMCID: PMC444663          DOI: 10.1128/AAC.6.4.418

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  9 in total

1.  Penicillinase and ampicillin resistance in a strain of Escherichia coli.

Authors:  J T SMITH
Journal:  J Gen Microbiol       Date:  1963-02

2.  R factors from Proteus rettgeri.

Authors:  J N Coetzee; N Datta; R W Hedges
Journal:  J Gen Microbiol       Date:  1972-10

3.  Resistance of Escherichia coli to penicillins. IV. Genetic study of mutants resistant to D,L-ampicillin concentrations o 100 mu-g-ml.

Authors:  H G Boman; K G Eriksson-Grennberg; S Normark; E Matsson
Journal:  Genet Res       Date:  1968-10       Impact factor: 1.588

4.  R-factor gene expression gram-negative bacteria.

Authors:  J T Smith
Journal:  J Gen Microbiol       Date:  1969-01

5.  Further studies on the antibiotic resistance of Shigella sonnei. I. Transferable antibiotic resistance.

Authors:  J R Davies; W N Farrant; A J Tomlinson
Journal:  J Hyg (Lond)       Date:  1968-09

6.  The ampicillin resistance of Shigella sonnei: its epidemiological value.

Authors:  G Scrimgeour
Journal:  Mon Bull Minist Health Public Health Lab Serv       Date:  1966-12

7.  Antibiotic resistance of Shigella sonnei.

Authors:  J R Davies; W N Farrant; A H Uttley
Journal:  Lancet       Date:  1970-12-05       Impact factor: 79.321

8.  The purification and properties of the -lactamase specified by the resistance factor R-1818 in Escherichia coli and Proteus mirabilis.

Authors:  J W Dale; J T Smith
Journal:  Biochem J       Date:  1971-07       Impact factor: 3.857

9.  Molecular specificities of R factor-determined beta-lactamases: correlation with plasmid compatibility.

Authors:  R W Hedges; N Datta; P Kontomichalou; J T Smith
Journal:  J Bacteriol       Date:  1974-01       Impact factor: 3.490

  9 in total
  4 in total

1.  Plasmid-determined beta-lactamase indistinguishable from the chromosomal beta-lactamase of Escherichia coli.

Authors:  M M Bobrowski; M Matthew; P T Barth; N Datta; N J Grinter; A E Jacob; P Kontomichalou; J W Dale; J T Smith
Journal:  J Bacteriol       Date:  1976-01       Impact factor: 3.490

2.  Antimicrobial resistance of Shigella isolated in New York City in 1973.

Authors:  H E Neu; C E Cherrubin; E D Longo; J Winter
Journal:  Antimicrob Agents Chemother       Date:  1975-06       Impact factor: 5.191

3.  Beta-lactamase activity in Shigella sonnei.

Authors:  A Prince; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1976-05       Impact factor: 5.191

4.  Shigella species from Addis Ababa: frequency of isolation and in vitro drug sensitivity.

Authors:  M Gedebou; A Tassew
Journal:  J Hyg (Lond)       Date:  1982-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.